COMP360
CompoundCompass Pathways' proprietary synthetic psilocybin formulation, using a specific crystalline form the company calls "Polymorph A."
Example: It's the furthest-along classic psychedelic in development, with two positive Phase 3 trials — see who actually holds the patents behind it and the contested legal fight over that crystal form.
What is COMP360?
Compass Pathways' proprietary synthetic psilocybin formulation, using a specific crystalline form the company calls "Polymorph A."
How far along is COMP360 in clinical development?
It's the furthest-along classic psychedelic in development, with two positive Phase 3 trials. See our coverage of who actually holds the patents behind it.
Is the COMP360 patent contested?
Yes — Compass Pathways has faced a legal fight from a nonprofit challenger over that crystal-form patent, and survived it. See the full fight over that patent.